Alexandre Weinstein Manieu bought $2.1M of Pluri (PLUR)
Executed Apr 28 2025, disclosed Nov 20 2025, 206 days later, against a two-business-day limit.
Over the 21 trading sessions from the disclosed entry session (Nov 20 2025), the stock returned -8.4% (delay-adjusted); from the execution session (Apr 28 2025), -14.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
Alexandre Weinstein Manieu (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in Pluri Inc. (PLUR). Across 1 priced purchase filing, the average 21-session return was -14.2% from execution and -8.4% from disclosure (delay-adjusted; derived). The largest single filing was $1.3M of PLUR (833,334 sh × $1.50, as filed), executed Oct 23.
Healthcare · Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and r…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→833,334 sh × $1.50
Exec Oct 23
Filed Oct 27 · 6:06 AM ET